Tumor-Activated Benzothiazole Inhibitors of Stearoyl-CoA Desaturase-Reference-Cited by-同舟云学术

Tumor-Activated Benzothiazole Inhibitors of Stearoyl-CoA Desaturase

Published:2020-08-05 Issue:17 Volume:63 Page:9773-9786
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Williams Noelle S.¹,Gonzales Stephen¹,Naidoo Jacinth¹,Rivera-Cancel Giomar¹²,Voruganti Sukesh¹,Mallipeddi Prema¹,Theodoropoulos Panayotis C.¹²,Geboers Sophie¹,Chen Hong¹,Ortiz Francisco¹,Posner Bruce¹,Nijhawan Deepak¹²^ORCID,Ready Joseph M.¹^ORCID

Affiliation:

1. Department of Biochemistry, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas 75390-9038, United States

2. Department of Internal Medicine, Division of Hematology and Oncology, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas 75390-9038, United States

Funder

Welch Foundation

Cancer Prevention and Research Institute of Texas

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00899

Reference34 articles.

1. How were new medicines discovered?

2. Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy

3. a The results published here are fully or partially based upon data generated by the Cancer Target Discovery and Development (CTD2) Network established by the National Cancer Institute’s Office of Cancer Genomics. See ‘Lung Cancer Oncogenotype-Selective Drug Target Discovery’ at https://ctd2.nci.nih.gov/dataPortal/.

4. Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer

5. Discovery of tumor-specific irreversible inhibitors of stearoyl CoA desaturase

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benzothiazole derivatives in the design of antitumor agents;Archiv der Pharmazie;2024-06-14

2. The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review;Biochemical Pharmacology;2024-05

3. SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors;Biomedicine & Pharmacotherapy;2024-01

4. Frentizole, a Nontoxic Immunosuppressive Drug, and Its Analogs Display Antitumor Activity via Tubulin Inhibition;International Journal of Molecular Sciences;2023-12-14

5. 2-Aminobenzothiazoles in anticancer drug design and discovery;Bioorganic Chemistry;2023-06